Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio González-García

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Drug Development and Industrial Pharmacy|July 3, 2015
In vitro-in vivo correlations: general concepts, methodologies and regulatory applicationsIgnacio González-García, Victor Mangas-Sanjuán, Matilde Merino-Sanjuán, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2025
An exposure-safety analysis to support the dosage of the novel AKT inhibitor capivasertibCarlos Fernandez Teruel, Marie Cullberg, Ignacio González-García, et al.
BMC Gastroenterology|September 4, 2010
Pneumomediastinum as a complication of emphysematous cholecystitis: case reportLuciano Delgado-Plasencia, Ignacio González-García, Diana Rodríguez-González, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 28, 2020
Two-step in vitro-in vivo correlations: Deconvolution and convolution methods, which one gives the best predictability? Comparison with one-step approachBárbara Sánchez-Dengra, Ignacio González-García, Marta González-Álvarez, et al.
Clinical and Translational Science|July 8, 2025
Population Pharmacokinetics and Exposure-Response Analyses for Capivasertib in Combination With Fulvestrant in Patients With Breast CancerCarlos Fernandez Teruel, Marie Cullberg, Ignacio González-García, et al.
World Journal of Hepatology|June 19, 2015
MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicineIván Lyra-González, Laura E Flores-Fong, Ignacio González-García, et al.
Hepatology International|July 24, 2015
Adenoviral gene therapy in hepatocellular carcinoma: a reviewIván Lyra-González, Laura Esther Flores-Fong, Ignacio González-García, et al.
Pharmaceutics|April 30, 2021
Pharmacokinetic-Pharmacodynamic Modelling of Systemic IL13 Blockade by Monoclonal Antibody Therapy: A Free Assay Disguised as TotalJohn Hood, Ignacio González-García, Nicholas White, et al.
The Journal of Craniofacial Surgery|January 26, 2013
Face transplant: is it feasible in developing countries?Ignacio González-García, Iván Lyra-González, David Medina-Preciado, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 19, 2021
Early predictions of response and survival from a tumor dynamics model in patients with recurrent, metastatic head and neck squamous cell carcinoma treated with immunotherapyIgnacio González-García, Vadryn Pierre, Vincent F S Dubois, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Drug Development and Industrial Pharmacy|July 3, 2015
In vitro-in vivo correlations: general concepts, methodologies and regulatory applicationsIgnacio González-García, Victor Mangas-Sanjuán, Matilde Merino-Sanjuán, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2025
An exposure-safety analysis to support the dosage of the novel AKT inhibitor capivasertibCarlos Fernandez Teruel, Marie Cullberg, Ignacio González-García, et al.
BMC Gastroenterology|September 4, 2010
Pneumomediastinum as a complication of emphysematous cholecystitis: case reportLuciano Delgado-Plasencia, Ignacio González-García, Diana Rodríguez-González, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 28, 2020
Two-step in vitro-in vivo correlations: Deconvolution and convolution methods, which one gives the best predictability? Comparison with one-step approachBárbara Sánchez-Dengra, Ignacio González-García, Marta González-Álvarez, et al.
Clinical and Translational Science|July 8, 2025
Population Pharmacokinetics and Exposure-Response Analyses for Capivasertib in Combination With Fulvestrant in Patients With Breast CancerCarlos Fernandez Teruel, Marie Cullberg, Ignacio González-García, et al.
World Journal of Hepatology|June 19, 2015
MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicineIván Lyra-González, Laura E Flores-Fong, Ignacio González-García, et al.
Hepatology International|July 24, 2015
Adenoviral gene therapy in hepatocellular carcinoma: a reviewIván Lyra-González, Laura Esther Flores-Fong, Ignacio González-García, et al.
Pharmaceutics|April 30, 2021
Pharmacokinetic-Pharmacodynamic Modelling of Systemic IL13 Blockade by Monoclonal Antibody Therapy: A Free Assay Disguised as TotalJohn Hood, Ignacio González-García, Nicholas White, et al.
The Journal of Craniofacial Surgery|January 26, 2013
Face transplant: is it feasible in developing countries?Ignacio González-García, Iván Lyra-González, David Medina-Preciado, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 19, 2021
Early predictions of response and survival from a tumor dynamics model in patients with recurrent, metastatic head and neck squamous cell carcinoma treated with immunotherapyIgnacio González-García, Vadryn Pierre, Vincent F S Dubois, et al.
Pageof 2